학술논문

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma
Document Type
Article
Source
In Blood 11 May 2023 141(19):2307-2315
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Immunobiology and Immunotherapy
Free Research Articles
Language
ISSN
0006-4971